ACME Resources Announces Results of Shareholder Meetings and RDT Financing

Toronto, Ontario--(Newsfile Corp. - September 5, 2018) - ACME Resources Corp. ("ACME" or the "Company") is pleased to announce the results of the ACME annual and special meeting of shareholders (the "ACME Meeting") and the results of the Rapid Dose Therapeutics Inc. ("RDT") special meeting of shareholders (the "RDT Meeting"), which were held on August 30 and 27, 2018, respectively.

Voting Results

At the ACME Meeting, shareholders holding approximately 52% of the outstanding shares were present in person or represented by proxy. The previously announced proposed amalgamation involving ACME, 1163926 B.C. Ltd., its wholly owned subsidiary, and RDT (the "Amalgamation") and all of the matters relating to the Amalgamation were approved by more than 99% of the votes cast by shareholders present in person or represented by proxy at the ACME Meeting.

At the RDT Meeting, shareholders holding approximately 85% of the outstanding shares were present in person or represented by proxy. The Amalgamation and all the matters relating to the Amalgamation were approved by 100% of the votes cast by shareholders present in person or represented by proxy.

RDT Financing

The Company is also pleased to announce that RDT has completed a private placement of 7,200,000 common shares at a price of $0.75 per share for gross proceeds of $5,400,000.

Amalgamation Transaction

For details of the proposed Amalgamation and other aspects of the Company's proposed reverse take-over transaction with RDT, please refer to ACME's news release filed on the Company's profile on SEDAR at www.sedar.com on July 12, 2018 and ACME's management information circular for the ACME Meeting filed on the Company's profile on SEDAR at www.sedar.com on August 9, 2018.

For more Information about ACME:

Visit ACME's profile at www.sedar.com.

Or contact Jorge Estepa, Corporate Secretary,

20 Adelaide Street East,
Suite 200,
Toronto, Ontario M5C 2T6
Tel: (416) 818-4035

Forward-Looking Statements

Information set forth in this news release involves forward-looking statements under applicable securities laws. The forward-looking statements contained herein include, but are not limited to, transactions described in or to be pursued pursuant to the Amalgamation Agreement such as the business combination with RDT, and all such forward-looking statements are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this document are made as of the date of this document and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation. Although management of the Company believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct and, accordingly, undue reliance should not be put on such forward-looking statements.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein.